Exercise boosts brain power in breast cancer survivors?
NCT ID NCT02934880
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a structured exercise program (adapted physical activity) could improve thinking and quality of life in women treated for locally advanced breast cancer. 37 women who had chemotherapy and reported memory or concentration problems took part. Half started exercise right away, the other half waited three months. The goal was to see if exercise could help their mental sharpness and overall well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- adapted physical activity (APA) program
- What this could lead to
- If it works, this could point toward a simple, drug-free way to help breast cancer patients think more clearly and feel better after chemotherapy.
- What could go wrong
- This is a very small, early study with only 37 participants. The results may not apply to everyone, and the benefit may be small or hard to measure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
37 people
The number who actually took part.
- Started
-
Jan 2017
- Finished
-
Jan 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women * More than 18 years old * Locally advanced breast cancer * Patient who undergone surgery * Cognitive complaint (FACT-COG inferior or equal to 8/16) * No metastasis at the inclusion * Patient who received adjuvant therapy by chemotherapy * Patient with a social protection * Barbizet scale Superior or equal to 3 * No neurological history * No medical contraindication to APA * Inform consent signed Exclusion Criteria: * Metastatic breast cancer * History of other cancer (in 5 years before inclusion) * Current chemotherapy or radiotherapy * Chemotherapy or radiotherapy ended for more than 6 months * Current APA program * Blood transfusion for less than 6 mois * Minimal mental score inferior to normal * Patient no able to respond to the cognitive test * Patient no able to realize APA program * Drug use * Alcohol abuse * Patient Under guardianship or curatorship or deprived of liberty
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre François Baclesse
Caen, 14076, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Oscar Lambret
Lille, 59000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?